Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-02-22 @ 6:44 PM
Study NCT ID:
NCT02614560
Status:
TERMINATED
Last Update Posted:
2019-01-09
First Post:
2015-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients
Sponsor:
Seagen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2017-02-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-20
First Submit QC Date:
None
Study First Post Date:
2015-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-05
Results First Submit QC Date:
None
Results First Post Date:
2019-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-12-20
Last Update Post Date:
2019-01-09
Last Update Post Date Type:
ACTUAL